Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses

常见变异型免疫缺陷的单细胞图谱显示B细胞反应中生发中心相关的表观遗传失调

阅读:2
作者:Javier Rodríguez-Ubreva # ,Anna Arutyunyan # ,Marc Jan Bonder ,Lucía Del Pino-Molina ,Stephen J Clark ,Carlos de la Calle-Fabregat ,Luz Garcia-Alonso ,Louis-François Handfield ,Laura Ciudad ,Eduardo Andrés-León ,Felix Krueger ,Francesc Català-Moll ,Virginia C Rodríguez-Cortez ,Krzysztof Polanski ,Lira Mamanova ,Stijn van Dongen ,Vladimir Yu Kiselev ,María T Martínez-Saavedra ,Holger Heyn ,Javier Martín ,Klaus Warnatz ,Eduardo López-Granados ,Carlos Rodríguez-Gallego ,Oliver Stegle ,Gavin Kelsey ,Roser Vento-Tormo ,Esteban Ballestar

Abstract

Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, displays impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and ample phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. Monozygotic (MZ) twins discordant for CVID are uniquely valuable for studying the contribution of epigenetics to the disease. Here, we generate a single-cell epigenomics and transcriptomics census of naïve-to-memory B cell differentiation in a CVID-discordant MZ twin pair. Our analysis identifies DNA methylation, chromatin accessibility and transcriptional defects in memory B-cells mirroring defective cell-cell communication upon activation. These findings are validated in a cohort of CVID patients and healthy donors. Our findings provide a comprehensive multi-omics map of alterations in naïve-to-memory B-cell transition in CVID and indicate links between the epigenome and immune cell cross-talk. Our resource, publicly available at the Human Cell Atlas, gives insight into future diagnosis and treatments of CVID patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。